Cancer is a group of diseases involving abnormal growth of cells with the potential to spread to other parts of the body.Cervical cancer diagnostics market is driven majorly by increasing percentage of HPV infected people across globe.

1. Published By:Zion Market Research
Cervical Cancer Diagnostics market - Global Industry
Perspective, Comprehensive Analysis and Forecast
2015-2021
Contact Us:
4283, Express Lane, Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +1-386-310-3803 GMT
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
sales@zionmarketresearch.com

2. Cervical Cancer Diagnostics market
Cancer is a group of diseases involving abnormal growth of cells with the potential to spread to
other parts of the body. There are various types of cancers affecting different parts of body.
Cancer which develops in cervix is called cervical cancer. Two major types of cervical cancers
diagnosed in women include adenocarcinoma and squamous cell carcinoma. Almost all types of
cervical cancer are caused by human papiloma virus (HPV). Cervical cancer is the third most
common cancer among women and the second most frequent cause of cancer-related death,
accounting for almost 3,00,000 deaths annually. Diagnosis of cervical cancer is done by Pap
Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC). Cervical cancer is a
sexually transmitted disease that can be prevented by early detection and vaccination.
Browse “Cervical Cancer Diagnostics market” Detail Report
at https://www.zionmarketresearch.com/report/cervical-cancer-diagnostics-market
Cervical cancer diagnostics market is driven majorly by increasing percentage of HPV infected
people across globe. HPV is an extremely common virus. According to the Centers for Disease

3. Cervical Cancer Diagnostics market
Control and Prevention (CDC), six million people in the United States acquire HPV each
year. At least 20 million already have it, and more than half of all sexually-active adults are
expected to be infected during their lifetime. Furthermore, rising awareness, literacy rate,
government initiatives, government funding and various screening methods are expected to
increase the growth of the market over the years. Moreover, many lifestyle-related factors, such
as having multiple sex partners, smoking, obesity, unsafe sex and inherited HPV positive
patients, are estimated to drive the cervical diagnostics market in the near future. However
prevention of HPV by vaccination is major restraining factor in the growth of cervical cancer
diagnostics market. In addition to this, the uncertain returning policy serves to be a major
challenge impacting the growth of cervical cancer diagnostics market.
Request Sample report at https://www.zionmarketresearch.com/sample/cervical-cancer-
diagnostics-market
The report covers forecast and analysis of the cervical cancer diagnostics market on a global and
regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021
based on revenue (USD Million). To understand the competitive landscape in the market, an

4. Cervical Cancer Diagnostics market
analysis of Porter’s Five Forces model for the cervical cancer diagnostics market has also been
included in the study. The report also analyzes several driving and restraining factors and their
impact on the market during the forecast period. The study encompasses a market attractiveness
analysis, wherein application segments are benchmarked based on their market size, growth
rate and general attractiveness.
The report provides detailed segmentation of the cervical cancer diagnostics market based on
application and region. The regional market segment held the largest market share in 2015.
Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin
America, and Middle East & Africa. North America dominated the global cervical cancer
diagnostic market in 2015 on account of the rising incidence of HPV infection, rising number of
women smokers, and growing aged population. North America was followed by Europe in 2015.
The market is expected to witness the growth in the Asia-Pacific region in the coming years due
to the rising HPV infection in population, government initiative and availability of advance
health care infrastructure.

5. Cervical Cancer Diagnostics market
Some of the key players contributing to the cervical cancer diagnostics market are Abbott
Laboratories, Qiagen N.V., Hologic Inc., Roche Diagnostics, Quest Diagnostics, Becton,
Dickinson and Company
This report segments the cervical cancer diagnostics market are follows:-
Cervical Cancer Diagnostics Market: Application Analysis
 Pap Smear Tests
 Colposcopy
 HPV Testing
Cervical Cancer Diagnostics Market: Regional Analysis
 North America
 Europe
 Asia Pacific

6. Cervical Cancer Diagnostics market
 Latin America
 Middle East & Africa
Browse “Cervical Cancer Diagnostics market” Detail Report
at https://www.zionmarketresearch.com/report/cervical-cancer-diagnostics-market
Zion Market Research
Address: 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States
Tel: +1-386-310-3803 GMT
+49-322 210 92714 Tel: +1-855-465-4651 (US/CAN TOLL FREE)
Email: sales@zionmarketresearch.comWeb:www.zionmarketresearch.com